Mimedx (MDXG) Cash & Equivalents Growth (3y) (2013 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -51.77% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 24.73% |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -28.55% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 13.33% |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -16.07% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 21.66% |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -8.88% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 36.53% |
| 10 | Mimedx | 530.69 Mn | 370.92 Mn | 41.62 Mn | 37.68% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 37.68% |
| Dec 31, 2025 | 36.06% |
| Sep 30, 2025 | 24.73% |
| Jun 30, 2025 | 17.92% |
| Mar 31, 2025 | 12.04% |
| Dec 31, 2024 | 6.24% |
| Sep 30, 2024 | -0.67% |
| Jun 30, 2024 | -6.70% |
| Mar 31, 2024 | -16.98% |
| Dec 31, 2023 | -5.06% |
| Jun 30, 2023 | 12.51% |
| Mar 31, 2023 | 4.60% |
| Dec 31, 2022 | -1.53% |
| Sep 30, 2022 | -8.03% |
| Jun 30, 2022 | -9.22% |
| Mar 31, 2022 | 38.67% |
| Dec 31, 2021 | 24.51% |
| Dec 31, 2020 | 51.64% |
| Sep 30, 2020 | 44.24% |
| Jun 30, 2020 | 0.47% |
| Mar 31, 2020 | 20.05% |
| Dec 31, 2019 | 31.58% |
| Sep 30, 2019 | 72.50% |
| Jun 30, 2019 | 59.67% |
| Mar 31, 2019 | 23.36% |
| Dec 31, 2018 | 19.71% |
| Dec 31, 2017 | -16.14% |
| Sep 30, 2017 | -8.23% |
| Jun 30, 2017 | 6.60% |
| Mar 31, 2017 | -10.42% |
| Dec 31, 2016 | -11.72% |
| Sep 30, 2016 | 44.63% |
| Jun 30, 2016 | 78.38% |
| Mar 31, 2016 | 38.22% |
| Dec 31, 2015 | 57.33% |
| Sep 30, 2015 | 75.33% |
| Jun 30, 2015 | 144.08% |
| Mar 31, 2015 | 133.97% |
| Dec 31, 2014 | 124.57% |
| Sep 30, 2014 | 320.13% |
| Jun 30, 2014 | 189.69% |
| Mar 31, 2014 | 248.03% |
| Dec 31, 2013 | 220.34% |